Hall DB - Search Results

1

Genotypic changes in human immunodeficiency virus type 1 protease associated with reduced susceptibility and virologic response to the protease inhibitor tipranavir.

Baxter JD, Schapiro JM, Boucher CA, Kohlbrenner VM, Hall DB, Scherer JR, Mayers DL. Baxter JD, et al. Among authors: hall db. J Virol. 2006 Nov;80(21):10794-801. doi: 10.1128/JVI.00712-06. Epub 2006 Aug 23. J Virol. 2006. PMID: 16928764 Free PMC article. Clinical Trial.

2

Improving the prediction of virological response to tipranavir: the development and validation of a tipranavir-weighted mutation score.

Schapiro JM, Scherer J, Boucher CA, Baxter JD, Tilke C, Perno CF, Maggiolo F, Santoro MM, Hall DB. Schapiro JM, et al. Among authors: hall db. Antivir Ther. 2010;15(7):1011-9. doi: 10.3851/IMP1670. Antivir Ther. 2010. PMID: 21041916

3

Seeking ethical designs for HIV clinical trials in treatment-experienced patients: an industry perspective.

Mayers DL, Chung J, Kohlbrenner VM, Hall DB, DeMasi RA, Neubacher D, Buss NE, Salgo MP. Mayers DL, et al. Among authors: hall db. AIDS Res Hum Retroviruses. 2006 Nov;22(11):1110-2. doi: 10.1089/aid.2006.22.1110. AIDS Res Hum Retroviruses. 2006. PMID: 17147497 No abstract available.

4

Alternating nevirapine and zidovudine treatment of human immunodeficiency virus type 1-infected persons does not prolong nevirapine activity.

de Jong MD, Loewenthal M, Boucher CA, van der Ende I, Hall D, Schipper P, Imrie A, Weigel HM, Kauffmann RH, Koster R, et al. de Jong MD, et al. J Infect Dis. 1994 Jun;169(6):1346-50. doi: 10.1093/infdis/169.6.1346. J Infect Dis. 1994. PMID: 8195615

5

Efficacy of short-course AZT plus 3TC to reduce nevirapine resistance in the prevention of mother-to-child HIV transmission: a randomized clinical trial.

McIntyre JA, Hopley M, Moodley D, Eklund M, Gray GE, Hall DB, Robinson P, Mayers D, Martinson NA. McIntyre JA, et al. Among authors: hall db. PLoS Med. 2009 Oct;6(10):e1000172. doi: 10.1371/journal.pmed.1000172. Epub 2009 Oct 27. PLoS Med. 2009. PMID: 19859531 Free PMC article. Clinical Trial.

6

Short-course Combivir after single-dose nevirapine reduces but does not eliminate the emergence of nevirapine resistance in women.

Palmer S, Boltz VF, Chow JY, Martinson NA, McIntyre JA, Gray GE, Hopley MJ, Mayers D, Robinson P, Hall DB, Maldarelli F, Coffin JM, Mellors JW; 1100.1413 Trial Investigators. Palmer S, et al. Among authors: hall db. Antivir Ther. 2012;17(2):327-36. doi: 10.3851/IMP1946. Epub 2011 Nov 3. Antivir Ther. 2012. PMID: 22293443 Free PMC article. Clinical Trial.

7

High-dose nevirapine in previously untreated human immunodeficiency virus type 1-infected persons does not result in sustained suppression of viral replication.

de Jong MD, Vella S, Carr A, Boucher CA, Imrie A, French M, Hoy J, Sorice S, Pauluzzi S, Chiodo F, Weverling GJ, van der Ende ME, Frissen PJ, Weigel HM, Kauffmann RH, Lange JM, Yoon R, Moroni M, Hoenderdos E, Leitz G, Cooper DA, Hall D, Reiss P. de Jong MD, et al. J Infect Dis. 1997 Apr;175(4):966-70. doi: 10.1086/514002. J Infect Dis. 1997. PMID: 9086161

8

Antiviral effect and pharmacokinetic interaction between nevirapine and indinavir in persons infected with human immunodeficiency virus type 1.

Murphy RL, Sommadossi JP, Lamson M, Hall DB, Myers M, Dusek A. Murphy RL, et al. Among authors: hall db. J Infect Dis. 1999 May;179(5):1116-23. doi: 10.1086/314703. J Infect Dis. 1999. PMID: 10191212 Clinical Trial.

9

Development of drug resistance in patients receiving combinations of zidovudine, didanosine and nevirapine.

Conway B, Wainberg MA, Hall D, Harris M, Reiss P, Cooper D, Vella S, Curry R, Robinson P, Lange JM, Montaner JS. Conway B, et al. AIDS. 2001 Jul 6;15(10):1269-74. doi: 10.1097/00002030-200107060-00008. AIDS. 2001. PMID: 11426071 Clinical Trial.

10

High-dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infection.

Havlir D, Cheeseman SH, McLaughlin M, Murphy R, Erice A, Spector SA, Greenough TC, Sullivan JL, Hall D, Myers M, et al. Havlir D, et al. J Infect Dis. 1995 Mar;171(3):537-45. doi: 10.1093/infdis/171.3.537. J Infect Dis. 1995. PMID: 7533197 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

119 results

Search Page

Filters